Location: Adelaide, Brisbane, Perth, Melbourne, Mulgrave
Clinical trials
At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk
Location: Adelaide, Brisbane
To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.
To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk
Location: Adelaide, Brisbane, Perth, Bundaberg
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
Location: Perth, Bundaberg
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Location: Melbourne, Mulgrave, Brisbane
To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.
Location: Brisbane
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Location: Newcastle , Perth, Brisbane, Bundaberg
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Location: Melbourne , Frankston
The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.
Location: Newcastle
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Location: Newcastle , Perth
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Location: Newcastle , Brisbane, Frankston, Melbourne
To evaluate a new valve in patients with severe mitral regurgitation
Location: Adelaide, Brisbane, Melbourne, Perth
To evaluate a new heart failure sensing device in patients with heart failure
Location: Brisbane
To evaluate a new medication for the treatment of recurrent pericarditis.
Location: Melbourne, Brisbane
To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients
Location: Brisbane, Joondalup
Clinical Trials
At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.
Heart Failure and Cardiac Resynchronisation Therapy
SMART
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
284 Kensington Road, Leabrook, SA 5068
Heart Failure and Cardiac Resynchronisation Therapy
SMART
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Heart Failure and Cardiac Resynchronisation Therapy
SMART
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
Heart Failure and Cardiac Resynchronisation Therapy
SMART
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083
Heart Failure and Cardiac Resynchronisation Therapy
SMART
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084
Heart Failure and Cardiac Resynchronisation Therapy
SMART
A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined. The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG).
Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170
Aortic Valve Stenosis
PORTICO-NG
To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk
284 Kensington Road, Leabrook, SA 5068
Aortic Valve Stenosis
PORTICO-NG
To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Aortic Valve Stenosis
PORTICO-NG
To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk
Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101
Atrial Fibrillation
OPTION
To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.
Ramsay Specialist Centre Suite 212, Level 2 Newdegate Street, Greenslopes, QLD, 4120
Cardiovascular Disease
VESALIUS
To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk
284 Kensington Road, Leabrook, SA 5068
Cardiovascular Disease
VESALIUS
To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Cardiovascular Disease
VESALIUS
To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk
Joondalup – Shenton House (Cardiology)
Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027
Cardiovascular Disease
VESALIUS
To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk
Friendly Society Private Hospital Bundaberg (Cardiology)
Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670
Type 2 Diabetes
SURPASS-2
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
Joondalup – Shenton House (Cardiology)
Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027
Type 2 Diabetes
SURPASS-2
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
Type 2 Diabetes
SURPASS-2
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
Friendly Society Private Hospital Bundaberg (Cardiology)
Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Heart Failure
HEART-FID
To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Mater Hospital, Sydney (Oncology)
The Mater Hospital, 25 Rocklands road, North Sydney, NSW
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
24 Salvado Road, Wembley WA, Australia
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Joondalup – Shenton House (Oncology)
Shenton House, Level 3, 57 Shenton Avenue, Joondalup, WA 6027
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Wesley Medical Centre (Oncology)
The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Bundaberg, Mater Hospital (Oncology), 313 Bourbong Street, Bundaberg, QLD, 4670
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Epping Medical Centre (Oncology)
Epping Medical Centre, Ground Floor, 230 Cooper Street, Epping, VIC, 3076
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Western Private Hospital, 1 Marion Street, Footscray, VIC 3011
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
St Vincent's Melbourne (Oncology)
St Vincent's Hospital, Basement Level, Building C, 41 Victoria Parade, Fitzroy, VIC, 3065
Brain Cancer
GBM001
The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Early Breast Cancer
POSNOC
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Early Breast Cancer
POSNOC
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Fiona Stanley Hospital (Oncology)
Discovery Way Murdoch University, Murdoch WA 6150, Australia
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Wesley Medical Centre (Oncology)
The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
St Andrew's Medical Centre (Cardiology & Sleep Medicine)
St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
284 Kensington Road, Leabrook, SA 5068
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Suite 3, 140 Mounts Bay Road, Perth, WA 6000
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
Heart Failure Device
COAST
To evaluate a new heart failure sensing device in patients with heart failure
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Cardiovascular disease and obesity
SELECT
To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Cardiovascular disease and obesity
SELECT
To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients
Joondalup Health Campus (Sleep Medicine)
Suite 103, Specialist Medical Centre West, Grand Blvd & Shenton Ave, Joondalup, WA, 6027